Can Clinitech Compete with Dr Lalpath and Thyrocare? - Clinitech Laboratory IPO Review
Clinitech Laboratory IPO opens for subscription on July 25, 2024 and closes on July 29, 2024. We recommend not investing in this SME IPO. But why? In this Clinitech Laboratory IPO review video we will answer this question for you. This Clinitech Laboratory IPO analysis video covers important points that you should consider like company's financials, valuation, competitive strength and more! For more latest IPO news and SME IPO review videos like this, subscribe to us!
About Clinitech Laboratory Limited:
Clinitech Laboratory, established in 1996, has carved a niche for itself in Navi Mumbai and Thane, India. Accredited by NABL for quality standards, they offer a comprehensive menu of tests across various fields like immunology, hematology, and biochemistry. Clinitech operates eight conveniently located branches, making diagnostic services accessible to a wider population. While not as widespread as Dr. Lal PathLabs, Clinitech prioritizes quality and patient convenience within their service area.
More Clinitech Laboratory IPO Details:
Clinitech Laboratory IPO price is ₹96 per share. The minimum lot size for an application is 1200 Shares. The minimum amount of investment required by retail investors is ₹115,200. The minimum lot size investment for HNI is 2 lots (2,400 shares) amounting to ₹230,400.
Join Us For all the latest updates about startups, preipo and unicorns.
Keep yourself updated with the market situation.
Join us on Facebook
Contact us at +91 7065560002 via Whatsapp/Normal call
Or Mail us at help@planify.in
⬇️ Download the app for easy access. Links are given below: